Biodesix, Inc. Consolidated Net Income/Loss

Consolidated Net Income/Loss of BDSX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Consolidated Net Income/Loss growth rates and interactive chart.


Highlights and Quick Summary

  • Consolidated Net Income/Loss for the quarter ending September 30, 2022 was $-13.7 Million (a -13.43% decrease compared to previous quarter)
  • Year-over-year quarterly Consolidated Net Income/Loss increased by 3.14%
  • Annual Consolidated Net Income/Loss for 2021 was $-43.2 Million (a 37.67% increase from previous year)
  • Annual Consolidated Net Income/Loss for 2020 was $-31.4 Million (a 2.03% increase from previous year)
  • Annual Consolidated Net Income/Loss for 2019 was $-30.7 Million (a 17.43% increase from previous year)
  • Twelve month Consolidated Net Income/Loss ending September 30, 2022 was $-58.4 Million (a 3.89% increase compared to previous quarter)
  • Twelve month trailing Consolidated Net Income/Loss increased by 35.29% year-over-year
Trailing Consolidated Net Income/Loss for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
$-58.4 Million $-56.2 Million $-51.8 Million $-43.2 Million
Visit stockrow.com/BDSX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Consolidated Net Income/Loss of Biodesix, Inc.

Most recent Consolidated Net Income/Lossof BDSX including historical data for past 10 years.

Interactive Chart of Consolidated Net Income/Loss of Biodesix, Inc.

Biodesix, Inc. Consolidated Net Income/Loss for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-13.7 $-15.82 $-15.59
2021 $-13.28 $-11.51 $-11.4 $-6.96 $-43.16
2020 $-4.53 $-8.85 $-8.27 $-9.71 $-31.35
2019 $-6.53 $-9.6 $-30.73
2018 $-26.17

Business Profile of Biodesix, Inc.

Sector: Healthcare
Industry: Diagnostics & Research